American Journal of Cardiology
Volume 100, Issue 11 , Pages 1609-1613, 1 December 2007

Prognostic Significance of Systolic Blood Pressure Increases in Men During Exercise Stress Testing

  • Manish Prakash Gupta, MD

      Affiliations

    • Lenox Hill Hospital, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 212-434-2551; fax: 212-434-2111.
  • ,
  • Sotir Polena, MD

      Affiliations

    • Lenox Hill Hospital, New York, New York
  • ,
  • Neil Coplan, MD

      Affiliations

    • Lenox Hill Hospital, New York, New York
  • ,
  • Georgia Panagopoulos, PhD

      Affiliations

    • Lenox Hill Hospital, New York, New York
  • ,
  • Charu Dhingra, MD

      Affiliations

    • PAVAHCS/Stanford University, Palo Alto, California.
  • ,
  • Jonathan Myers, PhD

      Affiliations

    • PAVAHCS/Stanford University, Palo Alto, California.
  • ,
  • Victor Froelicher, MD

      Affiliations

    • PAVAHCS/Stanford University, Palo Alto, California.

Received 17 April 2007; received in revised form 22 June 2007; accepted 22 June 2007. published online 16 October 2007.

Our aim was to investigate whether exercise-induced increase in systolic blood pressure (BP) measured during exercise stress testing (EST) adds prognostic information to cardiovascular (CV) mortality. EST is ideally suited to evaluate the prognostic power of systolic BP; it not only measures systolic BP response to exercise but also provides information about exercise capacity and other EST variables, which may affect the peak systolic BP. The study population consisted of 6,145 consecutive patients who underwent symptom-limited EST. Using the median value of change in systolic BP from baseline, patients were grouped according to exercise-induced increases in systolic BP ≤43 mm Hg (group A, n = 3,062) and ≥ 44 mm Hg (group B, n = 3,083). Multivariate analysis was used to adjust for baseline differences between the 2 groups with CV mortality as the end point for follow-up. Six thousand one hundred forty-five men underwent EST with a mean follow-up of 6.6 years. During follow-up, 676 patients died of CV causes with an average annual CV mortality of 1.6%. CV mortality was significantly higher in group A than in group B (13.7% vs 8.2%, p <0.001). After adjusting for baseline differences in the 2 groups using multivariate analysis, an increase in systolic BP of ≤44 mm Hg was a significant predictor of mortality (hazard ratio 1.2, 95% confidence interval 1.02 to 1.44, p <0.05). In conclusion, systolic BP response to maximal EST adds prognostic information to CV mortality independent of age, ST-segment abnormalities, and exercise capacity. In our study an increment in systolic BP of ≥44 mm Hg during EST was associated with a 23% improvement in survival over a mean follow-up of >6 years.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9149(07)01583-4

doi:10.1016/j.amjcard.2007.06.070

American Journal of Cardiology
Volume 100, Issue 11 , Pages 1609-1613, 1 December 2007